查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1668478

2025年類器官全球市場報告

Organoids Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年類器官市場將呈指數級成長。到 2029 年，這一數字將成長至 108.2 億美元，複合年成長率為 22.3%。預測期內的成長可歸因於慢性病盛行率的增加、基因組編輯技術的進步、幹細胞研究的增加、研究合作和夥伴關係以及臨床轉化工作。預測期內的關鍵趨勢包括再生醫學應用、體內成像技術、多器官系統的合作研究、倫理和法律考量、商業化和市場擴張。

慢性病和感染疾病的發生率和盛行率的不斷上升預計將推動未來類器官市場的成長。慢性病是一種持續時間超過一年並需要持續醫療照護的疾病。類器官被用於研究各種慢性疾病及其治療方法，為病原體生物學和藥物篩檢提供快速可靠的見解。因此，這些疾病的發生率和盛行率的增加將會增強類器官市場。例如，2024 年 6 月，英國公共醫療系統國家醫療服務體系 (NHS) 報告稱，2023 年在 GP 註冊的 3,615,330 名個人被診斷患有非糖尿病性高血糖症或糖尿病前期，高於 2022 年的 3,065,825 人，增幅約為 18%。因此，慢性病盛行率的上升預計將推動類器官市場的發展。

藥物開發臨床試驗數量的不斷成長也刺激了類器官市場的擴張。截至 2023 年 5 月 17 日，全球整體在 ClinicalTrials.gov 上註冊的此類臨床試驗已達 452,604 項，高於 2021 年初的 365,000 多項。這支持了類器官的廣泛應用。類器官用於疾病建模和改進個人化醫療，在促進科學理解和改善患者照護發揮關鍵作用，牢牢佔據市場成長的驅動力地位。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球類器官 PESTEL 分析（政治、社會、科技、環境、法律、促進因素、限制因素）
  • 最終用途產業分析
  • 全球類器官市場：成長率分析
  • 全球類器官市場表現：規模與成長，2019-2024
  • 全球類器官市場預測：規模與成長，2024-2029 年，2034 年
  • 全球類器官總目標市場（TAM）

第6章市場區隔

  • 全球類器官市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 肝臟類器官
  • 結腸類器官
  • 腸道類器官
  • 其他類器官
  • 全球類器官市場（按來源、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 多功能細胞
  • 器官特異性成體幹細胞
  • 全球類器官市場：依應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 發育生物學
  • 感染疾病病理學
  • 再生醫學
  • 藥物毒性和療效測試
  • 藥物研發與個人化醫療
  • 其他用途
  • 全球類器官市場：依最終使用者、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院和診斷中心
  • 生物技術和製藥公司
  • 其他最終用戶
  • 全球類器官市場，依類型細分：肝臟類器官，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 肝幹細胞衍生的類器官
  • 原代肝細胞衍生的類器官
  • 肝腫瘤類器官
  • 全球類器官市場，按類型細分：結腸類器官，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 結腸類器官
  • 直腸類器官
  • 結腸癌類器官
  • 全球類器官市場，按類型細分：腸道類器官，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 小腸類器官
  • 腸道類器官
  • 腸道幹細胞衍生的類器官
  • 全球類器官市場，依類型細分：其他類器官，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 胰臟類器官
  • 腦類器官
  • 腎臟類器官
  • 肺類器官
  • 其他

第7章 區域和國家分析

  • 全球類器官市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球類器官市場：依國家、表現及預測，2019-2024 年、2024-2029 年及 2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 類器官市場：競爭格局
  • 類器官市場：公司簡介
    • Cellesce Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • STEMCELL Technologies Overview, Products and Services, Strategy and Financial Analysis
    • HUB Organoids Overview, Products and Services, Strategy and Financial Analysis
    • DefiniGEN Overview, Products and Services, Strategy and Financial Analysis
    • 3Dnamics Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • OcellO BV
  • Organoid Therapeutics
  • PeproTech Inc.
  • QGel SA
  • Corning Incorporated
  • Thermo Fisher Scientific
  • Trevigen Inc.
  • Path BioAnalytics
  • R&D Systems
  • Merck KGaA
  • 3D BioMatrix Inc.
  • 3D Biotek LLC
  • AMS Biotechnology（Europe）Limited
  • Greiner Bio-One
  • 3-D Matrix

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年類器官市場：提供新機會的國家
  • 2029年類器官市場：細分領域蘊含新機會
  • 2029年類器官市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r24386

Organoids, intricate three-dimensional tissue cultures derived from stem cells, serve as invaluable assets in tailored regenerative medicine, gene repair, and transplantation therapy.

These organoids come in various forms such as hepatic, colorectal, and intestinal, among others. Hepatic organoids, for instance, represent fully functional in vitro models of the liver. They play a pivotal role in addressing an array of research queries related to hepatic development, regeneration, and disease modeling. These groundbreaking tools harness different sources, including pluripotent stem cells and organ-specific adult stem cells. They find application across developmental biology, infectious disease pathology, regenerative medicine, drug efficacy and toxicity testing, as well as drug discovery and personalized medicine. Their adoption spans a wide spectrum, encompassing hospitals, diagnostic centers, biotechnology and pharmaceutical companies, and other industries seeking to leverage their immense potential for advancements in healthcare and research.

The organoids market research report is one of a series of new reports from The Business Research Company that provides organoids market statistics, including organoids industry global market size, regional shares, competitors with a organoids market share, detailed organoids market segments, market trends, and opportunities, and any further data you may need to thrive in the organoids industry. This organoids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The organoids market size has grown exponentially in recent years. It will grow from$3.98 billion in 2024 to $4.83 billion in 2025 at a compound annual growth rate (CAGR) of 21.3%. The growth in the historic period can be attributed to biomedical research advances, drug discovery and development needs, disease modeling requirements, personalized medicine trends, and regulatory support

The organoids market size is expected to see exponential growth in the next few years. It will grow to $10.82 billion in 2029 at a compound annual growth rate (CAGR) of 22.3%. The growth in the forecast period can be attributed to the increased prevalence of chronic diseases, advancements in genome editing techniques, rise in stem cell research, collaborations and partnerships, and clinical translation efforts. Major trends in the forecast period include application in regenerative medicine, in vivo imaging techniques, collaborations for multi-organoid systems, ethical and legal considerations, commercialization and market expansion.

An increase in the incidence and prevalence of chronic and infectious diseases is expected to drive the growth of the organoid market in the future. Chronic diseases are conditions that persist for over a year and require continuous medical care. Organoids are utilized to investigate various chronic diseases and their treatments, as they provide immediate and reliable insights into pathogen biology and drug screening. Thus, the rise in the incidence and prevalence of these diseases will bolster the organoid market. For example, in June 2024, the National Health Service, a publicly funded healthcare system in the UK, reported that 3,615,330 individuals registered with a GP were diagnosed with non-diabetic hyperglycemia, or pre-diabetes, in 2023, up from 3,065,825 in 2022, representing an increase of nearly 18%. Therefore, the growing prevalence of chronic diseases is expected to propel the organoid market.

The escalating number of clinical trials aimed at drug development is set to fuel the expansion of the organoid market. These trials, totaling 452,604 globally as of May 17, 2023, registered on ClinicalTrials.gov-an increase from over 365,000 trials in early 2021, underscore the growing utilization of organoids. Leveraged in modeling diseases and refining personalized medicine, organoids play a pivotal role in advancing scientific understanding and improving patient care, solidifying their contribution to market growth.

Technological advancements stand as a prominent trend shaping the organoid market. Companies within this sector continuously introduce cutting-edge technologies to fortify their market positions. Notably, in March 2023, MIMETAS unveiled the OrganoReady product line featuring a novel adult stem cell-derived tubular organoid, harnessing innovative technology for mechanistic toxicology and drug-induced organ injury assessments. Developed on the patented microfluidic platform, OrganoPlate, these perfused 3D structures demonstrate the industry's commitment to pioneering advancements in organoid technologies.

Market leaders prioritize the development of pioneering platforms such as organoid panel screening, driving progress in preclinical oncology drug discovery. For example, in November 2023, Crown Bioscience launched OrganoidXplore, a revolutionary large-scale organoid panel screening platform. Utilizing their AR organoid technology, this platform streamlines preclinical drug discovery by offering reliable drug response comparisons that faithfully replicate original tumors' genomic, morphological, and pathophysiological characteristics. With enhanced performance and cost-effectiveness, OrganoidXplore signals a significant stride in accelerating oncology drug discovery.

In December 2022, Molecular Devices LLC, a UK-based research and development company, acquired Cellesce Ltd. for an undisclosed amount. The acquisition will provide Molecular Devices LLC with Cellesce Ltd human-derived cell or organoid lines and strengthen the company's position as a 3D biology solutions innovator. Cellesce Ltd is a UK-based company with expertise in cell expansion focused on organoids.

Major companies operating in the organoids market include Cellesce Ltd., STEMCELL Technologies, HUB Organoids, DefiniGEN, 3Dnamics Inc., OcellO B.V., Organoid Therapeutics, PeproTech Inc., QGel SA, Corning Incorporated, Thermo Fisher Scientific, Trevigen Inc., Path BioAnalytics, R&D Systems, Merck KGaA, 3D BioMatrix Inc., 3D Biotek LLC, AMS Biotechnology (Europe) Limited, Greiner Bio-One, 3-D Matrix, InSphero AG, Synthego Corporation, Axol Bioscience Ltd., TissUse GmbH, CytoSMART Technologies BV, EMD Millipore Corporation, Epithelix Sarl

North America was the largest region in the organoids market in 2024. Asia-pacific is expected to be the fastest-growing region in the global organoids market size forecast period. The regions covered in the organoids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the organoids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The organoids market consists of sales of epithelial organoid, embryonic organoid, and cerebral organoid. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Organoids Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on organoids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for organoids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The organoids market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Hepatic Organoid; Colorectal Organoid; Intestinal Organoid; Other Organoid
  • 2) By Source: Pluripotent Stem Cells; Organ-Specific Adult Stem Cells
  • 3) By Application: Developmental Biology; Disease Pathology Of Infectious Disease; Regenerative Medicine; Drug Toxicity And Efficacy Testing; Drug Discovery And Personalized Medicine; Other Applications
  • 4) By End-User: Hospitals And Diagnostic Centers; Biotechnology And Pharmaceutical Companies; Other End-Users
  • Subsegments:
  • 1) By Hepatic Organoid: Hepatic Stem Cell-Derived Organoids; Primary Liver Cell-Derived Organoids; Liver Tumor Organoids
  • 2) By Colorectal Organoid: Colonic Organoids; Rectal Organoids; Colorectal Cancer Organoids
  • 3) By Intestinal Organoid: Small Intestinal Organoids; Enteroid Organoids; Intestinal Stem Cell-Derived Organoids
  • 4) By Other Organoid: Pancreatic Organoids; Brain Organoids; Kidney Organoids; Lung Organoids; Others
  • Companies Mentioned: Cellesce Ltd.; STEMCELL Technologies; HUB Organoids; DefiniGEN; 3Dnamics Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Organoids Market Characteristics

3. Organoids Market Trends And Strategies

4. Organoids Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Organoids Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Organoids PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Organoids Market Growth Rate Analysis
  • 5.4. Global Organoids Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Organoids Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Organoids Total Addressable Market (TAM)

6. Organoids Market Segmentation

  • 6.1. Global Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hepatic Organoid
  • Colorectal Organoid
  • Intestinal Organoid
  • Other Organoid
  • 6.2. Global Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pluripotent Stem Cells
  • Organ-Specific Adult Stem Cells
  • 6.3. Global Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Developmental Biology
  • Disease Pathology Of Infectious Disease
  • Regenerative Medicine
  • Drug Toxicity And Efficacy Testing
  • Drug Discovery And Personalized Medicine
  • Other Applications
  • 6.4. Global Organoids Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Diagnostic Centers
  • Biotechnology And Pharmaceutical Companies
  • Other End-Users
  • 6.5. Global Organoids Market, Sub-Segmentation Of Hepatic Organoid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hepatic Stem Cell-Derived Organoids
  • Primary Liver Cell-Derived Organoids
  • Liver Tumor Organoids
  • 6.6. Global Organoids Market, Sub-Segmentation Of Colorectal Organoid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Colonic Organoids
  • Rectal Organoids
  • Colorectal Cancer Organoids
  • 6.7. Global Organoids Market, Sub-Segmentation Of Intestinal Organoid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Small Intestinal Organoids
  • Enteroid Organoids
  • Intestinal Stem Cell-Derived Organoids
  • 6.8. Global Organoids Market, Sub-Segmentation Of Other Organoid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pancreatic Organoids
  • Brain Organoids
  • Kidney Organoids
  • Lung Organoids
  • Others

7. Organoids Market Regional And Country Analysis

  • 7.1. Global Organoids Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Organoids Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Organoids Market

  • 8.1. Asia-Pacific Organoids Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Organoids Market

  • 9.1. China Organoids Market Overview
  • 9.2. China Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Organoids Market

  • 10.1. India Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Organoids Market

  • 11.1. Japan Organoids Market Overview
  • 11.2. Japan Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Organoids Market

  • 12.1. Australia Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Organoids Market

  • 13.1. Indonesia Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Organoids Market

  • 14.1. South Korea Organoids Market Overview
  • 14.2. South Korea Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Organoids Market

  • 15.1. Western Europe Organoids Market Overview
  • 15.2. Western Europe Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Organoids Market

  • 16.1. UK Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Organoids Market

  • 17.1. Germany Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Organoids Market

  • 18.1. France Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Organoids Market

  • 19.1. Italy Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Organoids Market

  • 20.1. Spain Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Organoids Market

  • 21.1. Eastern Europe Organoids Market Overview
  • 21.2. Eastern Europe Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Organoids Market

  • 22.1. Russia Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Organoids Market

  • 23.1. North America Organoids Market Overview
  • 23.2. North America Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Organoids Market

  • 24.1. USA Organoids Market Overview
  • 24.2. USA Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Organoids Market

  • 25.1. Canada Organoids Market Overview
  • 25.2. Canada Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Organoids Market

  • 26.1. South America Organoids Market Overview
  • 26.2. South America Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Organoids Market

  • 27.1. Brazil Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Organoids Market

  • 28.1. Middle East Organoids Market Overview
  • 28.2. Middle East Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Organoids Market

  • 29.1. Africa Organoids Market Overview
  • 29.2. Africa Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Organoids Market Competitive Landscape And Company Profiles

  • 30.1. Organoids Market Competitive Landscape
  • 30.2. Organoids Market Company Profiles
    • 30.2.1. Cellesce Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. STEMCELL Technologies Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. HUB Organoids Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. DefiniGEN Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. 3Dnamics Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Organoids Market Other Major And Innovative Companies

  • 31.1. OcellO B.V.
  • 31.2. Organoid Therapeutics
  • 31.3. PeproTech Inc.
  • 31.4. QGel SA
  • 31.5. Corning Incorporated
  • 31.6. Thermo Fisher Scientific
  • 31.7. Trevigen Inc.
  • 31.8. Path BioAnalytics
  • 31.9. R&D Systems
  • 31.10. Merck KGaA
  • 31.11. 3D BioMatrix Inc.
  • 31.12. 3D Biotek LLC
  • 31.13. AMS Biotechnology (Europe) Limited
  • 31.14. Greiner Bio-One
  • 31.15. 3-D Matrix

32. Global Organoids Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Organoids Market

34. Recent Developments In The Organoids Market

35. Organoids Market High Potential Countries, Segments and Strategies

  • 35.1 Organoids Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Organoids Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Organoids Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer